Eric Schlorff
First SEC filing: Nov. 1, 2022 · Latest: Nov. 1, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2026 | ICUCW | A | 10,288 | · | · | 50,140 Direct | +25.82% | Acquired | (price as of 2026-10-02) |
| Feb. 6, 2026 | ICUCW | A | 30,000 | · | · | 39,852 Direct | +304.51% | Acquired | (price as of 2026-10-02) |
| July 1, 2025 | ICUCW | M | 21,667 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| July 1, 2025 | ICUCW | M | 21,667 | · | · | 98,517 Direct | +28.19% | Acquired | (price as of 2026-10-02) |
| Nov. 15, 2024 | ICUCW | A | 65,000 | · | · | 65,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 29, 2023 | ICUCW | A | 60,248 | · | · | 837,823 Direct | +7.75% | Acquired | (price as of 2026-10-02) |
| Sept. 15, 2023 | ICUCW | A | 41,109 | · | · | 779,862 Direct | +5.56% | Acquired | (price as of 2026-10-02) |
| Aug. 31, 2023 | ICUCW | A | 33,750 | · | · | 736,466 Direct | +4.80% | Acquired | (price as of 2026-10-02) |
| Aug. 31, 2023 | ICUCW | A | 35,178 | · | · | 738,753 Direct | +5.00% | Acquired | (price as of 2026-10-02) |
| Aug. 15, 2023 | ICUCW | A | 20,317 | · | · | 702,176 Direct | +2.98% | Acquired | (price as of 2026-10-02) |
| Aug. 15, 2023 | ICUCW | A | 21,176 | · | · | 703,575 Direct | +3.10% | Acquired | (price as of 2026-10-02) |
| June 23, 2023 | ICUCW | A | 417,386 | · | · | 682,399 Direct | +157.50% | Acquired | (price as of 2026-10-02) |
| April 6, 2023 | ICUCW | A | 99,724 | · | · | 99,724 Direct | · | Acquired | (price as of 2026-10-02) |
| April 6, 2023 | ICUCW | A | 66,483 | · | · | 265,013 Direct | +33.49% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2022 | ICUCW | A | 83,985 | · | · | 83,985 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2022 | ICUCW | A | 17,986 | · | · | 17,986 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2022 | ICUCW | A | 198,530 | · | · | 198,530 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2025 | ICUCW | Restricted Stock Unit | Common Stock, par value $0.0001 per share | · | · | 21,667 | Disposed |
| Nov. 15, 2024 | ICUCW | Restricted Stock Unit | Common Stock, par value $0.0001 per share | · | · | 65,000 | Acquired |
| April 6, 2023 | ICUCW | Stock Option (Right to Buy) | Common Stock | $1.84 | April 6, 2033 | 99,724 | Acquired |
| Oct. 28, 2022 | ICUCW | Stock Option (Right to Buy) | Common Stock | $0.53 | Feb. 20, 2030 | 83,985 | Acquired |
| Oct. 28, 2022 | ICUCW | Stock Option (Right to Buy) | Common Stock | $10.00 | March 1, 2029 | 17,986 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $406,500 | · | · | · | · | · | · | $406,500 |
| 2024 | $420,000 | · | · | · | · | · | · | $562,350 |
| 2023 | $420,000 | · | $97,863 | · | · | · | · | $637,960 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.